BRPI0603783A - composições e métodos para redução do ph vaginal - Google Patents

composições e métodos para redução do ph vaginal

Info

Publication number
BRPI0603783A
BRPI0603783A BRPI0603783-6A BRPI0603783A BRPI0603783A BR PI0603783 A BRPI0603783 A BR PI0603783A BR PI0603783 A BRPI0603783 A BR PI0603783A BR PI0603783 A BRPI0603783 A BR PI0603783A
Authority
BR
Brazil
Prior art keywords
vaginal
compositions
methods
reduction
reducing
Prior art date
Application number
BRPI0603783-6A
Other languages
English (en)
Inventor
Nawaz Ahmad
Cheng-Ji Cui
Ann Fu
Shun Y Lin
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/224,189 external-priority patent/US20060172007A1/en
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0603783A publication Critical patent/BRPI0603783A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIçõES E MéTODOS PARA REDUçãO DO pH VAGINAL. A presente invenção refere-se a composições tamponadas aquosas e métodos para redução pH vaginal e redução do nível do odor vaginal autopercebido. Tais composições podem ser aplicadas à área vaginal para reduzir o pH vaginal e ajudar a manter tal pH durante um período de tempo.
BRPI0603783-6A 2005-09-12 2006-09-12 composições e métodos para redução do ph vaginal BRPI0603783A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/224,189 US20060172007A1 (en) 2001-05-01 2005-09-12 Compositions and methods for reducing vaginal pH
US11/224,870 US20060105008A1 (en) 2002-03-28 2005-09-13 Compositions and methods for reducing vaginal pH

Publications (1)

Publication Number Publication Date
BRPI0603783A true BRPI0603783A (pt) 2007-06-12

Family

ID=37606858

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603783-6A BRPI0603783A (pt) 2005-09-12 2006-09-12 composições e métodos para redução do ph vaginal

Country Status (6)

Country Link
US (1) US20060105008A1 (pt)
EP (1) EP1764100A3 (pt)
JP (1) JP2007077152A (pt)
AU (1) AU2006208421A1 (pt)
BR (1) BRPI0603783A (pt)
CA (1) CA2559510A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009155118A1 (en) * 2008-05-30 2009-12-23 Reprotect, Inc. Compositions and methods for inactivation of pathogens at genital tract surfaces
CA2776921A1 (en) 2009-10-08 2011-04-14 Phlora Bio-Technology Investment Limited A composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
US9155873B2 (en) 2011-05-17 2015-10-13 Reprotect, Inc. Reusable intravaginal delivery device, system, and method
SG11201408243VA (en) 2012-06-13 2015-01-29 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
EA036748B1 (ru) 2016-04-06 2020-12-16 Гедеа Биотек Аб Глюконо--лактон для лечения вагинальных грибковых инфекций
AU2017338748A1 (en) * 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis
WO2019068862A1 (en) * 2017-10-06 2019-04-11 Gedea Biotech Ab GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS
EP3863620A4 (en) * 2018-10-09 2022-08-03 Crapaud Bio, Inc. METHODS OF MAKING AND USING PH MODULATING COMPOSITIONS IN THE REPRODUCTIVE SYSTEM
JP2022007545A (ja) * 2020-06-26 2022-01-13 小林製薬株式会社 粘膜洗浄用組成物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
JPS58164683A (ja) * 1982-03-25 1983-09-29 Takeda Chem Ind Ltd 安定化された固体組成物
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
GR940100370A (el) * 1993-07-28 1994-07-26 Johnson & Johnson Consumer Products Inc. Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
AU747451B2 (en) * 1997-06-20 2002-05-16 Ohkura Pharmaceutical Co., Ltd. Gelled composition
MXPA99011298A (es) * 1997-07-14 2004-10-28 Adolor Corp Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
US20060172007A1 (en) * 2001-05-01 2006-08-03 Nawaz Ahmad Compositions and methods for reducing vaginal pH
US20030064103A1 (en) 2001-05-01 2003-04-03 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
US20070059278A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Anhydrous composition containing an acid-acid buffer system

Also Published As

Publication number Publication date
CA2559510A1 (en) 2007-03-12
EP1764100A2 (en) 2007-03-21
US20060105008A1 (en) 2006-05-18
AU2006208421A1 (en) 2007-03-29
EP1764100A3 (en) 2009-04-08
JP2007077152A (ja) 2007-03-29

Similar Documents

Publication Publication Date Title
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
GT200100152A (es) Nueva composicion farmaceutica para el tratamiento de la obesidad.
AU2016204344A1 (en) Improved methods and compositions for wound healing
CR7944S (es) Juguete para morder para animales
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
ATE521334T1 (de) Schweisshemmende oder desodorierende zusammensetzung
CO5611137A2 (es) Composiciones de clorhidrato de naltrexona
EA200870019A1 (ru) Лактамовые соединения и способы их применения
IL172364A (en) Variant of vii or viia factor at gla site
SG151303A1 (en) New compounds for the inhibition of angiogenesis and use thereof
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
EP2046361A4 (en) OSTEOUS AMPLIFIER COMPOSITION
TW200716183A (en) Parakeratosis inhibitor, pore-contracting agent and external composition for skin
MX373170B (es) Variantes de la familia il-1.
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
BRPI0603783A (pt) composições e métodos para redução do ph vaginal
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
CR8545A (es) Piperidinilcarbonil-pirrolidinas y su empleo comoagonistas de melanocortina
NI200300045A (es) Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
ATE469886T1 (de) 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen
AR039664A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan
DE60329326D1 (de) Tace inhibitoren
UA97346C2 (ru) Стабильная эмульсионная композиция
ATE372150T1 (de) Verwendung von speziellen polyolen zur kristallisationsinhibierung von oniumaldehyden bzw. -ketonen
GB2416123A (en) Stable carprofen composition

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired